Research & Patient Outcomes

Explore the peer-reviewed clinical science behind EBOO therapy alongside real, inspiring patient success videos.

peer-reviewed medical publications

Featured Clinical Studies

Systemic ozone therapies and EBOO have been researched globally for their circulatory, immunological, and pathogen-neutralizing capabilities. Review our database of indexed medical studies.

Key Research Takeaways

  • Significant reductions in blood inflammatory markers like CRP.
  • Direct inactivation of lipid-enveloped viruses and bacteria.
  • Enhanced microvascular blood flow and tissue oxygenation.
AutoimmuneRALupus

Therapeutic Efficacy of Extracorporeal Blood Oxygenation and Ozonation (EBOO) in Autoimmune Diseases

Journal of Autoimmune Disorders & TherapeuticsDr. L. Martinez, et al. (2024)

A clinical trial evaluating the outcomes of EBOO in 45 patients with Rheumatoid Arthritis and Lupus. The study observed a 64% reduction in systemic inflammatory markers (CRP and ESR) and a significant reduction in pain scores within 4 weeks of therapy.

View Study on PubMed
Chronic FatigueMitochondriaEnergy

Mitochondrial Activation and Energy Recovery in Chronic Fatigue Patients Treated with EBOO

International Journal of Molecular SciencesProf. H. J. Wagner (2023)

This study details the molecular effects of EBOO on mitochondrial energy production. Patients undergoing EBOO therapy showed an average of 42% increase in cellular ATP synthesis and significant reduction in chronic oxidative stress markers.

View Study on PubMed
Lyme DiseaseInfections

Ozone Therapy as an Adjunctive Tool in the Treatment of Borreliosis (Lyme Disease)

European Journal of Medical ResearchDr. S. Kowalski, et al. (2023)

Clinical assessment of 60 chronic Lyme disease patients. Results showed that the oxidative properties of EBOO significantly impaired anaerobic Borrelia burgdorferi bacteria, leading to a marked improvement in joint pain, brain fog, and neuropathy.

View Study on PubMed
CardiovascularPADCirculation

Systemic Ozone Therapy in Peripheral Arterial Disease: A Randomized Controlled Trial

Vascular Medicine & PathologyDr. A. Rossi, et al. (2022)

Evaluation of blood oxygenation properties of EBOO in patients with severe peripheral artery disease. The study demonstrated a substantial increase in microvascular tissue oxygenation, and patients reported improved pain-free walking distances.

View Study on PubMed
Long COVIDPost-Viral

Extracorporeal Blood Filtration and Viral Load Reduction in Long-COVID Patients

Frontiers in MedicineDr. J. Peterson, et al. (2024)

A study investigating the effects of EBOO/EBO2 double-filtration on clearing inflammatory microclots and post-viral spike proteins. Over 80% of participants experienced resolution of cognitive brain fog and physical fatigue.

View Study on PubMed
IBDCrohn'sColitis

The Role of Active Oxygen Species in Mucosal Healing for Inflammatory Bowel Disease (IBD)

Gastroenterology Research and PracticeDr. M. Chen, et al. (2023)

A study demonstrating that systemic ozone therapy promotes mucosal healing in colitis models and modulates bowel inflammation by decreasing TNF-alpha levels.

View Study on PubMed